Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.1B | 9.1B | 8.5B | 8.4B |
Cost of revenue | 3.0B | 3.1B | 3.3B | 3.2B |
Gross profit | 5.2B | 6.0B | 5.2B | 5.2B |
Operating expense | ||||
Research & development | 1.5B | 1.7B | 1.5B | 1.4B |
Selling general and admin | 1.7B | 1.9B | 1.6B | 1.8B |
Other operating expenses | 830M | 61M | 71M | 11M |
Operating income | 1.2B | 2.3B | 2.0B | 1.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 723M | 747M | 776M | 808M |
Other income expense | 1.5B | -782M | 1.8B | -307M |
Pretax income | 2.0B | 782M | 3.1B | 794M |
Tax provision | 243M | 155M | 271M | 48M |
Net income | 1.7B | 627M | 2.8B | 746M |
Basic EPS | 3.2 | 1.2 | 5.3 | 1.4 |
Diluted EPS | 3.2 | 1.2 | 5.2 | 1.4 |
Basic average shares | 538M | 537M | 537M | 537M |
Diluted average shares | 541M | 542M | 542M | 541M |
EBITDA | 4.1B | 2.9B | 5.3B | 3.0B |
Net income from continuing op. | 1.7B | 627M | 2.8B | 746M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |